{{Rsnum
|rsid=1424941
|Gene=ACVR2A
|Chromosome=2
|position=147885549
|Orientation=minus
|GMAF=0.1295
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ACVR2A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 28.3 | 69.0
| HCB | 1.5 | 19.7 | 78.8
| JPT | 2.7 | 15.9 | 81.4
| YRI | 0.0 | 1.4 | 98.6
| ASW | 0.0 | 14.0 | 86.0
| CHB | 1.5 | 19.7 | 78.8
| CHD | 2.8 | 14.8 | 82.4
| GIH | 2.0 | 24.8 | 73.3
| LWK | 0.0 | 18.2 | 81.8
| MEX | 0.0 | 19.0 | 81.0
| MKK | 0.0 | 15.4 | 84.6
| TSI | 6.9 | 42.2 | 51.0
| HapMapRevision=28
}}

This SNP is located on chromosome 2q22-23, in the activin receptor type 2 gene ([[ACVR2A]]) gene.

A study of 1139 Norwegian women with one or more pre-eclamptic pregnancies and 2269 controls (women with normal pregnancies) identified four SNPs in this region ([[rs1424941]], [[rs1014064]], [[rs2161983]] and [[rs3768687]]) as associated with higher risk for [[pre-eclampsia]].{{PMID|18781190|OA=1
}}

{{PMID|19126782|OA=1
}} Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}